Dr. Mary J. Burton is heading up a COVID-19 study in collaboration with GlaxoSmithKline LLC entitled “A randomized, double-blind, placebo-controlled, study evaluation the efficacy and safety of otilimab IV in patients with severe pulmonary COVID-19 related disease.” Thanks to Dr. Burton for her continued research of Infectious Diseases especially related to the pandemic.